Harvest Fund Management Co. Ltd Purchases 1,435 Shares of HCA Healthcare, Inc. $HCA

Harvest Fund Management Co. Ltd lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 92.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,990 shares of the company’s stock after acquiring an additional 1,435 shares during the quarter. Harvest Fund Management Co. Ltd’s holdings in HCA Healthcare were worth $1,395,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in HCA. Norges Bank bought a new stake in HCA Healthcare in the fourth quarter valued at about $1,262,513,000. Life Cycle Investment Partners Ltd bought a new stake in HCA Healthcare in the fourth quarter valued at about $374,037,000. Viking Global Investors LP increased its holdings in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after purchasing an additional 690,773 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after purchasing an additional 649,058 shares during the last quarter. Finally, Danske Bank A S bought a new stake in HCA Healthcare in the third quarter valued at about $115,530,000. Institutional investors own 62.73% of the company’s stock.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

HCA Healthcare Price Performance

HCA stock opened at $372.29 on Friday. The stock has a market capitalization of $82.59 billion, a P/E ratio of 12.80, a P/E/G ratio of 1.15 and a beta of 1.12. The business has a 50-day moving average of $439.51 and a 200-day moving average of $477.20. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s quarterly revenue was up 4.3% on a year-over-year basis. During the same period in the prior year, the company earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio is 10.73%.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. dropped their price objective on HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating for the company in a report on Tuesday, May 19th. Leerink Partners decreased their target price on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Jefferies Financial Group reissued a “buy” rating and issued a $525.00 target price on shares of HCA Healthcare in a research note on Friday, April 24th. Finally, Robert W. Baird decreased their target price on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research note on Wednesday, April 15th. Sixteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $506.14.

Get Our Latest Report on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Featured Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.